WEKO3
インデックスリンク
アイテム
The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile.
http://hdl.handle.net/2297/48442
http://hdl.handle.net/2297/4844270c249a4-b7e9-411d-ad17-6ec1c2b2edc3
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-10-03 | |||||
タイトル | ||||||
タイトル | The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Kometani, Mitsuhiro
× Kometani, Mitsuhiro× Yoneda, Takashi× Demura, Masashi× Karashima, Shigehiro× Mori, Shunsuke× Oe, Masashi× Sawamura, Toshitaka× Okuda, Rika× Yamagishi, Masakazu× Takeda, Yoshiyu |
|||||
書誌情報 |
Internal Medicine 巻 55, 号 7, p. 769-773, 発行日 2016-04-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0918-2918 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA10827774 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.2169/internalmedicine.55.5196 | |||||
出版者 | ||||||
出版者 | Japanese Society of Internal Medicine = 日本内科学会 | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not candidate for surgical treatment. The present case was a 39-year-old woman with u-PA, who had refused surgery, had suffered from adverse effects of medical treatment. She was treated with transcatheter adrenal arterial embolization (TAAE). Her blood pressure had been well controlled without progression of cardiorenovascular damage for 12 years. TAAE can be the third treatment option for u-PA patients. © 2016 The Japanese Society of Internal Medicine. | |||||
権利 | ||||||
権利情報 | Copyright © 2016 The Japanese Society of Internal Medicine | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
関連URI | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.jstage.jst.go.jp/browse/internalmedicine | |||||
関連URI | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://www.naika.or.jp/ |